This week, Principal Scientist, Cell Therapy, Amy Becker is at #SITC2020 presenting Intellia’s #CRISPR /Cas9 screening platform to identify knockout targets in primary T cells in the tumor microenvironment. #genomeediting https://t.co/5KD1edHN36